346 related articles for article (PubMed ID: 34026654)
1. LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
Lv Y; Lv X; Yang H; Qi X; Wang X; Li C; Shang X; Guo H; Zhang J; Zhang Y
Front Oncol; 2021; 11():678474. PubMed ID: 34026654
[TBL] [Abstract][Full Text] [Related]
2. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
Du F; Guo T; Cao C
Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p.
Liu XF; Wang K; Du HC
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7598-7611. PubMed ID: 32744686
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer.
Lv P; Qiu X; Gu Y; Yang X; Xu X; Yang Y
Biomed Pharmacother; 2019 Feb; 110():294-301. PubMed ID: 30522015
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy.
Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G
Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923
[TBL] [Abstract][Full Text] [Related]
6. Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.
Bao C; Liu T; Qian L; Xiao C; Zhou X; Ai H; Wang J; Fan W; Pan J
J Cancer; 2021; 12(1):76-88. PubMed ID: 33391404
[No Abstract] [Full Text] [Related]
7. Knockdown of lncRNA BDNF-AS inhibited the progression of multiple myeloma by targeting the miR-125a/b-5p-BCL2 axis.
Chu M; Fan Y; Wu L; Ma X; Sao J; Yao Y; Zhuang W; Zhang C
Immun Ageing; 2022 Jan; 19(1):3. PubMed ID: 34980181
[TBL] [Abstract][Full Text] [Related]
8. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer.
Wang C; Tao W; Ni S; Chen Q
J Cell Biochem; 2019 Jan; 120(1):357-367. PubMed ID: 30168179
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis.
Wang YQ; Huang G; Chen J; Cao H; Xu WT
Breast Cancer Res Treat; 2021 Jul; 188(1):1-14. PubMed ID: 33782812
[TBL] [Abstract][Full Text] [Related]
12. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SNHG6 functions as a competing endogenous RNA by sponging miR-181a-5p to regulate E2F5 expression in colorectal cancer.
Yu C; Sun J; Leng X; Yang J
Cancer Manag Res; 2019; 11():611-624. PubMed ID: 30666158
[TBL] [Abstract][Full Text] [Related]
14. lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis.
Wang SM; Pang J; Zhang KJ; Zhou ZY; Chen FY
Mol Ther Oncolytics; 2021 Jun; 21():62-73. PubMed ID: 33869743
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG6 accelerates nasopharyngeal carcinoma progression via modulating miR-26a-5p/ARPP19 axis.
Yin X; Gu X; Li F; Ye F; Liu F; Wang W
Bioorg Med Chem Lett; 2021 May; 40():127955. PubMed ID: 33744438
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-483-5p improves the proliferation, invasion and inflammatory response of triple-negative breast cancer cells by targeting SOCS3.
Ren J; Xu G; Sun H; Lin T; Xu S; Zhao Y
Exp Ther Med; 2021 Oct; 22(4):1047. PubMed ID: 34434261
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells.
Wang X; Lan Z; He J; Lai Q; Yao X; Li Q; Liu Y; Lai H; Gu C; Yan Q; Fang Y; Zhang Y; Li A; Liu S
Cancer Cell Int; 2019; 19():234. PubMed ID: 31516391
[TBL] [Abstract][Full Text] [Related]
19. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
[TBL] [Abstract][Full Text] [Related]
20. LINC00514 upregulates CCDC71L to promote cell proliferation, migration and invasion in triple-negative breast cancer by sponging miR-6504-5p and miR-3139.
Luo X; Wang H
Cancer Cell Int; 2021 Mar; 21(1):180. PubMed ID: 33757509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
